IP Library › Assignment 035143/0812
Patent Assignment
Reel/Frame 035143/0812

Assignment of Assignor's Interest

Recorded: 2015-03-11 Pages: 3
Assignor
KIRN, DAVID
Executed: 2006-11-27
Assignee
JENNEREX BIOTHERAPEUTICS ULC
ONE MARKET, SPEAR TOWER, SUITE 2260, SAN FRANCISCO, CALIFORNIA, 94105
Covered Property (1)
Oncolytic Vaccinia Virus Cancer Therapy
Patent: 8,980,246 →
Application: 13/535,291 →
Publication: US 2012/0276053
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Jul 22, 2014
From: JENNEREX, INC.
To: SILLAJEN BIOTHERAPEUTICS, INC.
Reel/Frame 033381/0217 →
Corrective Assignment to Correct the Assignee Street Address Previously Recorded at Reel: 033381 Frame: 0217. Assignor(S) Hereby Confirms the Assignment. Sep 4, 2014
From: JENNEREX, INC.
To: SILLAJEN BIOTHERAPEUTICS, INC.
Reel/Frame 033760/0388 →
Assignment of Assignor's Interest Mar 11, 2015
From: KIRN, DAVID
To: JENNEREX, INC.
Reel/Frame 035143/0879 →
Assignment of Assignor's Interest Mar 11, 2015
From: JENNEREX BIOTHERAPEUTICS ULC
To: JENNEREX, INC.
Reel/Frame 035143/0908 →